Skip to content

Clinical trials

Lymphoma trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma Country / region: China Clear all

275 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20073
20082
20093
20102
20113
20123
20135
20147
201510
201619
201716
201817
201914
202018
202126
202236
202329
202416
202525
202618

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status117
Recruiting68
Completed51
Active, not recruiting15
Not yet recruiting13
Withdrawn4
Terminated4
Suspended3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Peking University11
Ruijin Hospital11
Chinese PLA General Hospital10
Institute of Hematology & Blood Diseases Hospital, China8
Fudan University7
Hebei Senlang Biotechnology Inc., Ltd.6
Southwest Hospital, China6
Sun Yat-sen University6
Takeda5
Affiliated Hospital to Academy of Military Medical Sciences4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma275
Leukemia40
Recurrence28
Lymphoma, B-Cell21
Multiple Myeloma20
Lymphoma, Large B-Cell, Diffuse16
Lymphoma, Non-Hodgkin15
Leukemia, Myeloid, Acute14
Leukemia, Lymphocytic, Chronic, B-Cell11
Lymphoma, Follicular11

Trials

Showing 76 to 100 of 275. Each trial links to its page on Pharma Observatory.

175 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.